Literature DB >> 18687807

Ligand activation of peroxisome proliferator-activated receptor-beta/delta inhibits cell proliferation in human HaCaT keratinocytes.

Michael G Borland1, Jennifer E Foreman, Elizabeth E Girroir, Reza Zolfaghari, Arun K Sharma, Shantu Amin, Frank J Gonzalez, A Catharine Ross, Jeffrey M Peters.   

Abstract

Although there is strong evidence that ligand activation of peroxisome proliferator-activated receptor (PPAR)-beta/delta induces terminal differentiation and attenuates cell growth, some studies suggest that PPARbeta/delta actually enhances cell proliferation. For example, it was suggested recently that retinoic acid (RA) is a ligand for PPARbeta/delta and potentiates cell proliferation by activating PPARbeta/delta. The present study examined the effect of ligand activation of PPARbeta/delta on cell proliferation, cell cycle kinetics, and target gene expression in human HaCaT keratinocytes using two highly specific PPARbeta/delta ligands [4-[[[2-[3-fluoro-4-(trifluoromethyl)phenyl]-4-methyl-5-thiazolyl]methyl]thio]-2-methylphenoxy acetic acid (GW0742) and 2-methyl-4-((4-methyl-2-(4-trifluoromethylphenyl)-1,3-thiazol-5-yl)-methylsulfanyl)phenoxy-acetic acid (GW501516)] and RA. Both PPARbeta/delta ligands and RA inhibited cell proliferation of HaCaT keratinocytes. GW0742 and GW501516 increased expression of known PPARbeta/delta target genes, whereas RA did not; RA increased the expression of known retinoic acid receptor/retinoid X receptor target genes, whereas GW0742 did not affect these genes. GW0742, GW501516, and RA did not modulate the expression of 3-phosphoinositide-dependent protein kinase or alter protein kinase B phosphorylation. GW0742 and RA increased annexin V staining as quantitatively determined by flow cytometry. The effects of GW0742 and RA were also examined in wild-type and PPARbeta/delta-null primary mouse keratinocytes to determine the specific role of PPARbeta/delta in modulating cell growth. Although inhibition of keratinocyte proliferation by GW0742 was PPARbeta/delta-dependent, inhibition of cell proliferation by RA occurred in both genotypes. Results from these studies demonstrate that ligand activation of PPARbeta/delta inhibits keratinocyte proliferation through PPARbeta/delta-dependent mechanisms. In contrast, the observed inhibition of cell proliferation in mouse and human keratinocytes by RA is mediated by PPARbeta/delta-independent mechanisms and is inconsistent with the notion that RA potentiates cell proliferation by activating PPARbeta/delta.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18687807      PMCID: PMC2672040          DOI: 10.1124/mol.108.050609

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.054


  53 in total

1.  Critical roles of PPAR beta/delta in keratinocyte response to inflammation.

Authors:  N S Tan; L Michalik; N Noy; R Yasmin; C Pacot; M Heim; B Flühmann; B Desvergne; W Wahli
Journal:  Genes Dev       Date:  2001-12-15       Impact factor: 11.361

2.  Novel peroxisome proliferator-activated receptor (PPAR) gamma and PPARdelta ligands produce distinct biological effects.

Authors:  J Berger; M D Leibowitz; T W Doebber; A Elbrecht; B Zhang; G Zhou; C Biswas; C A Cullinan; N S Hayes; Y Li; M Tanen; J Ventre; M S Wu; G D Berger; R Mosley; R Marquis; C Santini; S P Sahoo; R L Tolman; R G Smith; D E Moller
Journal:  J Biol Chem       Date:  1999-03-05       Impact factor: 5.157

3.  Loss of retinoic acid receptors in mouse skin and skin tumors is associated with activation of the ras(Ha) oncogene and high risk for premalignant progression.

Authors:  N Darwiche; G Scita; C Jones; S Rutberg; E Greenwald; T Tennenbaum; S J Collins; L M De Luca; S H Yuspa
Journal:  Cancer Res       Date:  1996-11-01       Impact factor: 12.701

4.  Keratinocyte differentiation is stimulated by activators of the nuclear hormone receptor PPARalpha.

Authors:  K Hanley; Y Jiang; S S He; M Friedman; P M Elias; D D Bikle; M L Williams; K R Feingold
Journal:  J Invest Dermatol       Date:  1998-04       Impact factor: 8.551

5.  Modulation of keratinocyte gene expression and differentiation by PPAR-selective ligands and tetradecylthioacetic acid.

Authors:  M Westergaard; J Henningsen; M L Svendsen; C Johansen; U B Jensen; H D Schrøder; I Kratchmarova; R K Berge; L Iversen; L Bolund; K Kragballe; K Kristiansen
Journal:  J Invest Dermatol       Date:  2001-05       Impact factor: 8.551

6.  Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta(delta).

Authors:  J M Peters; S S Lee; W Li; J M Ward; O Gavrilova; C Everett; M L Reitman; L D Hudson; F J Gonzalez
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

Review 7.  Regulatory functions of PPARbeta in metabolism: implications for the treatment of metabolic syndrome.

Authors:  Paul A Grimaldi
Journal:  Biochim Biophys Acta       Date:  2007-02-24

8.  Activation of nuclear hormone receptor peroxisome proliferator-activated receptor-delta accelerates intestinal adenoma growth.

Authors:  Rajnish A Gupta; Dingzhi Wang; Sharada Katkuri; Haibin Wang; Sudhansu K Dey; Raymond N DuBois
Journal:  Nat Med       Date:  2004-02-01       Impact factor: 53.440

9.  Peroxisome proliferator-activated receptor beta (delta)-dependent regulation of ubiquitin C expression contributes to attenuation of skin carcinogenesis.

Authors:  Dae J Kim; Taro E Akiyama; Fred S Harman; Amanda M Burns; Weiwei Shan; Jerrold M Ward; Mary J Kennett; Frank J Gonzalez; Jeffrey M Peters
Journal:  J Biol Chem       Date:  2004-03-19       Impact factor: 5.157

10.  Peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) ligands inhibit growth of UACC903 and MCF7 human cancer cell lines.

Authors:  Elizabeth E Girroir; Holly E Hollingshead; Andrew N Billin; Timothy M Willson; Gavin P Robertson; Arun K Sharma; Shantu Amin; Frank J Gonzalez; Jeffrey M Peters
Journal:  Toxicology       Date:  2007-11-04       Impact factor: 4.571

View more
  32 in total

1.  PPARs and lipid ligands in inflammation and metabolism.

Authors:  Gregory S Harmon; Michael T Lam; Christopher K Glass
Journal:  Chem Rev       Date:  2011-10-12       Impact factor: 60.622

2.  The relationship of diet and acne: A review.

Authors:  Apostolos Pappas
Journal:  Dermatoendocrinol       Date:  2009-09

Review 3.  The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention.

Authors:  Jeffrey M Peters; Yatrik M Shah; Frank J Gonzalez
Journal:  Nat Rev Cancer       Date:  2012-02-09       Impact factor: 60.716

Review 4.  Pregnane xenobiotic receptor in cancer pathogenesis and therapeutic response.

Authors:  Satyanarayana R Pondugula; Sridhar Mani
Journal:  Cancer Lett       Date:  2012-08-29       Impact factor: 8.679

Review 5.  Retinoids: Potent regulators of metabolism.

Authors:  Pierre-Jacques Brun; Kryscilla Jian Zhang Yang; Seung-Ah Lee; Jason J Yuen; William S Blaner
Journal:  Biofactors       Date:  2012-12-22       Impact factor: 6.113

6.  Modulation of aryl hydrocarbon receptor (AHR)-dependent signaling by peroxisome proliferator-activated receptor β/δ (PPARβ/δ) in keratinocytes.

Authors:  Michael G Borland; Prasad Krishnan; Christina Lee; Prajakta P Albrecht; Weiwei Shan; Moses T Bility; Craig B Marcus; Jyh M Lin; Shantu Amin; Frank J Gonzalez; Gary H Perdew; Jeffrey M Peters
Journal:  Carcinogenesis       Date:  2014-03-17       Impact factor: 4.944

Review 7.  Dissecting the role of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) in colon, breast, and lung carcinogenesis.

Authors:  Jeffrey M Peters; Jennifer E Foreman; Frank J Gonzalez
Journal:  Cancer Metastasis Rev       Date:  2011-12       Impact factor: 9.264

Review 8.  Vitamin A signaling and homeostasis in obesity, diabetes, and metabolic disorders.

Authors:  William S Blaner
Journal:  Pharmacol Ther       Date:  2019-01-29       Impact factor: 12.310

9.  Activation of peroxisome proliferator-activated receptor-β/δ (PPAR-β/δ) inhibits human breast cancer cell line tumorigenicity.

Authors:  Pei-Li Yao; Jose L Morales; Bokai Zhu; Boo-Hyon Kang; Frank J Gonzalez; Jeffrey M Peters
Journal:  Mol Cancer Ther       Date:  2014-01-24       Impact factor: 6.261

Review 10.  The roles of endogenous retinoid signaling in organ and appendage regeneration.

Authors:  Nicola Blum; Gerrit Begemann
Journal:  Cell Mol Life Sci       Date:  2013-03-12       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.